Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs NEULAND LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA NEULAND LABS AJANTA PHARMA/
NEULAND LABS
 
P/E (TTM) x 38.3 25.4 150.7% View Chart
P/BV x 8.3 8.1 102.6% View Chart
Dividend Yield % 0.3 0.2 196.5%  

Financials

 AJANTA PHARMA   NEULAND LABS
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
NEULAND LABS
Mar-23
AJANTA PHARMA/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs1,4262,004 71.1%   
Low Rs1,062966 110.0%   
Sales per share (Unadj.) Rs297.2928.4 32.0%  
Earnings per share (Unadj.) Rs46.7127.4 36.6%  
Cash flow per share (Unadj.) Rs57.1168.6 33.9%  
Dividends per share (Unadj.) Rs7.0010.00 70.0%  
Avg Dividend yield %0.60.7 83.6%  
Book value per share (Unadj.) Rs269.1774.8 34.7%  
Shares outstanding (eoy) m125.9112.83 981.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.21.6 261.7%   
Avg P/E ratio x26.611.7 228.6%  
P/CF ratio (eoy) x21.88.8 247.4%  
Price / Book Value ratio x4.61.9 241.3%  
Dividend payout %15.07.8 191.1%   
Avg Mkt Cap Rs m156,63819,052 822.2%   
No. of employees `000NANA-   
Total wages/salary Rs m7,8512,018 389.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m37,42611,912 314.2%  
Other income Rs m98697 1,011.9%   
Total revenues Rs m38,41312,009 319.9%   
Gross profit Rs m7,8332,718 288.1%  
Depreciation Rs m1,308528 247.8%   
Interest Rs m58131 44.7%   
Profit before tax Rs m7,4532,157 345.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,573522 301.1%   
Profit after tax Rs m5,8801,635 359.6%  
Gross profit margin %20.922.8 91.7%  
Effective tax rate %21.124.2 87.2%   
Net profit margin %15.713.7 114.4%  
BALANCE SHEET DATA
Current assets Rs m28,2527,609 371.3%   
Current liabilities Rs m11,3934,390 259.5%   
Net working cap to sales %45.027.0 166.7%  
Current ratio x2.51.7 143.1%  
Inventory Days Days666 1,034.5%  
Debtors Days Days101,109 0.9%  
Net fixed assets Rs m18,7078,189 228.4%   
Share capital Rs m253129 195.9%   
"Free" reserves Rs m33,6249,812 342.7%   
Net worth Rs m33,8779,941 340.8%   
Long term debt Rs m13742 1.7%   
Total assets Rs m47,04715,798 297.8%  
Interest coverage x128.617.5 734.5%   
Debt to equity ratio x00.1 0.5%  
Sales to assets ratio x0.80.8 105.5%   
Return on assets %12.611.2 112.9%  
Return on equity %17.416.4 105.5%  
Return on capital %22.221.4 103.5%  
Exports to sales %59.973.5 81.6%   
Imports to sales %11.515.1 75.7%   
Exports (fob) Rs m22,4208,750 256.2%   
Imports (cif) Rs m4,2931,804 238.0%   
Fx inflow Rs m22,4208,750 256.2%   
Fx outflow Rs m4,2931,804 238.0%   
Net fx Rs m18,1276,946 261.0%   
CASH FLOW
From Operations Rs m7,9182,372 333.8%  
From Investments Rs m-5,596-615 909.9%  
From Financial Activity Rs m-1,079-1,358 79.4%  
Net Cashflow Rs m1,243403 308.3%  

Share Holding

Indian Promoters % 66.2 32.8 201.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.8 29.1 88.5%  
FIIs % 9.1 22.7 40.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 33.8 67.2 50.3%  
Shareholders   54,351 27,723 196.1%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs NEULAND LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs NEULAND LABS Share Price Performance

Period AJANTA PHARMA NEULAND LABS S&P BSE HEALTHCARE
1-Day 2.51% -1.12% 1.18%
1-Month 7.60% -11.56% -0.75%
1-Year 92.91% 269.91% 61.82%
3-Year CAGR 21.63% 43.81% 18.16%
5-Year CAGR 26.85% 59.26% 19.79%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the NEULAND LABS share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 66.2% stake in the company. In case of NEULAND LABS the stake stands at 32.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of NEULAND LABS.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 7.0 per share. This amounted to a Dividend Payout ratio of 15.0%.

NEULAND LABS paid Rs 10.0, and its dividend payout ratio stood at 7.8%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of NEULAND LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.